Zumiez, Tesla fall; Okta, Calavo Growers rise
June 3, 2022 GMTNEW YORK (AP) — Stocks that traded heavily or had substantial price changes Friday:
Turning Point Therapeutics Inc., up $40.43 to $74.59.
Bristol Myers Squibb is buying the biopharmaceutical company for about $4.1 billion.
Zumiez: Fiscal Q1 Earnings Snapshot
June 2, 2022 GMTLYNNWOOD, Wash. (AP) _ Zumiez Inc. (ZUMZ) on Thursday reported a loss of $397,000 in its fiscal first quarter.
On a per-share basis, the Lynnwood, Washington-based company said it had a loss of 2 cents.
Zumiez: Fiscal Q4 Earnings Snapshot
March 10, 2022 GMTLYNNWOOD, Wash. (AP) _ Zumiez Inc. (ZUMZ) on Thursday reported fiscal fourth-quarter profit of $38.2 million.
On a per-share basis, the Lynnwood, Washington-based company said it had net income of $1.70.
ADVERTISEMENT